Asensus Surgical, Inc. (NYSEAMERICAN:ASXC) Short Interest Update

Asensus Surgical, Inc. (NYSEAMERICAN:ASXC) saw a significant drop in short interest in May. As of May 31st, there was short interest totalling 12,910,000 shares, a drop of 10.3% from the May 15th total of 14,400,000 shares. Approximately 4.8% of the company’s shares are short sold. Based on an average daily volume of 2,310,000 shares, the days-to-cover ratio is presently 5.6 days.

Analyst Ratings Changes

Separately, HC Wainwright reissued a “neutral” rating and set a $0.35 price target on shares of Asensus Surgical in a research report on Thursday, May 16th.

Asensus Surgical Stock Down 1.8 %

NYSEAMERICAN ASXC traded down $0.01 during trading on Tuesday, reaching $0.33. The company’s stock had a trading volume of 3,204,269 shares, compared to its average volume of 1,856,159. The company has a market capitalization of $88.86 million, a P/E ratio of -1.05 and a beta of 1.28. Asensus Surgical has a 12 month low of $0.20 and a 12 month high of $0.65.

Asensus Surgical (NYSEAMERICAN:ASXC) last posted its quarterly earnings data on Tuesday, May 14th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.02). The business had revenue of $1.12 million during the quarter, compared to the consensus estimate of $1.10 million. Asensus Surgical had a negative net margin of 902.25% and a negative return on equity of 184.10%. Equities analysts expect that Asensus Surgical will post -0.24 EPS for the current year.

Institutional Trading of Asensus Surgical

A hedge fund recently raised its stake in Asensus Surgical stock. Virtu Financial LLC lifted its position in shares of Asensus Surgical, Inc. (NYSEAMERICAN:ASXC) by 834.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 249,019 shares of the company’s stock after buying an additional 222,368 shares during the quarter. Virtu Financial LLC owned about 0.09% of Asensus Surgical worth $57,000 at the end of the most recent reporting period. 9.35% of the stock is currently owned by institutional investors and hedge funds.

About Asensus Surgical

Asensus Surgical, Inc, a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients.